EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access

Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus

Sabine Bou-Antoun, Rebecca C Oettle, Alistair Leanord, Ronald Andrew Seaton iD, Ben S Cooper, Berit Muller-Pebody, Geraldine Conlon-Bingham, Frances Kerr, Kieran S Hand, Jonathan A T Sandoe iD, Martin J Llewelyn iD, Naomi Fleming und 7 weitere

JAC-Antimicrobial Resistance · 26.12.2024 · 7 (1)

DOI: 10.1093/jacamr/dlae218 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 16.01.2025. Verfasst von Sabine Bou-Antoun und 18 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial Resistance (AMR) and Healthcare-Associated Infection (HCAI) Division, United Kingdom Health Security Agency (UKHSA), London, UK. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: UKHSA’s HCAI, UKRI MRC, National Institute for Health Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In 2017, the WHO introduced the AWaRe (Access, Watch and Reserve) classification of antibiotics to support antibiotic stewardship (AMS) at local, national and global levels. We assessed the categorization of each of the antibiotics for systemic use for antimicrobial stewardship and quality improvement practice across primary and secondary care in the UK, proposing a nationally adapted UK-AWaRe classification.

Methods

A four-stage modified Delphi survey was conducted to review the AWaRe classifications in light of antibiotic resistance profiles, antibiotic use and stewardship practice in the UK. Recommendations were iteratively discussed and consensus reached on how to adapt the WHO AWaRe list. Implications of the proposed new categorization for possible antibiotic usage targets were assessed using England national antibiotic consumption data as a case study.

Results

Sixty-one experts across the four UK nations participated in the modified Delphi process. Consensus was most easily reached, with least between-expert variation, for Access antibiotics. Seventeen antibiotics differed in categorization when comparing proposed adapted UK-AWaRe classification and the 2023 WHO AWaRe classification. Through the focus group discussions, the importance of clear messaging was highlighted for the proposed move of first-generation cephalosporins into the Access category, a step-change from the 2019 England AWaRe classification, where all cephalosporins were in the Watch category. From the case study analysis of national data in England, Access antibiotics accounted for >60% of human antibiotic use between 2018 and 2022, 69.7% when using the WHO 2023 classification and 63.7% with the proposed UK-adapted 2024 classification.

Conclusions

An adapted UK-AWaRe list has been suggested through a consensus-reaching process. This will support national AMS and antibiotic usage targets of the UK antimicrobial resistance 2024–29 national action plan.

Autor:innen und Institutionen

  • Antimicrobial Resistance (AMR) and Healthcare-Associated Infection (HCAI) Division, United Kingdom Health Security Agency (UKHSA), London, UK.
  • Infection and Immunity, MVLS, University of Glasgow, Glasgow, Scotland, UK.
  • Department of Infectious Diseases, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, Scotland, UK.
  • Scottish Antimicrobial Prescribing Group, NHS Healthcare Improvement Scotland, Glasgow, Scotland, UK.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Pharmacy Department, Southern Health and Social Care Trust, Craigavon, Northern Ireland, UK.

ORCID-Profile: Ronald Andrew Seaton, Jonathan A T Sandoe, Martin J Llewelyn, Philip Howard, Alicia Demirjian, Diane Ashiru-Oredope

Förderung

  • UKHSA’s HCAI
  • UKRI MRC
  • National Institute for Health Research
  • Health Protection Research Unit
  • Healthcare Associated Infections and Antimicrobial Resistance
  • Imperial College London
  • University of Oxford

Zitieren

APA

Bou-Antoun, S., Oettle, R. C., Leanord, A., Seaton, R. A., Cooper, B. S., Muller-Pebody, B., Conlon-Bingham, G., Kerr, F., Hand, K. S., Sandoe, J. A. T., Llewelyn, M. J., Fleming, N., Brown, N. M., Reid, N., Howard, P., Mckinstry, S. J., Malcolm, W., Demirjian, A., & Ashiru-Oredope, D. (2024). Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus. JAC-Antimicrobial Resistance, 7(1). https://doi.org/10.1093/jacamr/dlae218

Vancouver

Bou-Antoun S, Oettle RC, Leanord A, Seaton RA, Cooper BS, Muller-Pebody B, et al. Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus. JAC-Antimicrobial Resistance. 2024;7(1). doi:10.1093/jacamr/dlae218

BibTeX
@article{BouAntoun2024,
  author = {Bou-Antoun, Sabine and Oettle, Rebecca C and Leanord, Alistair and Seaton, Ronald Andrew and Cooper, Ben S and Muller-Pebody, Berit and Conlon-Bingham, Geraldine and Kerr, Frances and Hand, Kieran S and Sandoe, Jonathan A T and Llewelyn, Martin J and Fleming, Naomi and Brown, Nicholas M and Reid, Nicholas and Howard, Philip and Mckinstry, Sarah-Jayne and Malcolm, William and Demirjian, Alicia and Ashiru-Oredope, Diane},
  title = {Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus},
  journal = {JAC-Antimicrobial Resistance},
  year = {2024},
  volume = {7},
  number = {1},
  doi = {10.1093/jacamr/dlae218}
}
Kostenlos starten →